Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Fresenius Kabi Oncology Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

Looking for Drug Master Files (DMF) for 32615 of Fresenius Kabi Oncology Ltd

Looking for Drug Master Files (DMF) for 32615 of Fresenius Kabi Oncology Ltd 1

20

Fresenius Kabi Oncology Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.

One of their notable products is PLERIXAFOR, with a corresponding US DMF Number 32615.

Remarkably, this DMF maintains an Inactive status since its submission on May 18, 2018, highlighting commitment to regulatory compliance.